Assignee
CONVERGENCE PHARMACEUTICALS
GB·12 granted patents·7 pending applications·30 citations·filing 2006–2019
Top patents by PatentIndex Score
19 records- 0188US7855218B2CompoundsCONVERGENCE PHARMACEUTICALS·Filed 2006·Granted Dec 21, 2010·13 cites·16 claims
- 0285US9737536B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2016·Granted Aug 22, 2017·3 cites·13 claims
- 0384US9376445B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2013·Granted Jun 28, 2016·4 cites·11 claims
- 0483US10010551B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2017·Granted Jul 3, 2018·2 cites·10 claims
- 0583US9309254B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2013·Granted Apr 12, 2016·4 cites·24 claims
- 0679US10485801B2Pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2018·Granted Nov 26, 2019·1 cites·14 claims
- 0772US2020289508A1Novel pyrimidinyl-diazospiro compoundsCONVERGENCE PHARMACEUTICALS·Filed 2019·Application pending·0 cites
- 0867US10421716B2Process for preparing alpha-carboxamide pyrrolidine derivativesCONVERGENCE PHARMACEUTICALS·Filed 2015·Granted Sep 24, 2019·1 cites·26 claims
- 0967US9376436B22-(pyridin-2yl)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulatorsCONVERGENCE PHARMACEUTICALS·Filed 2012·Granted Jun 28, 2016·1 cites·12 claims
- 1059US9303032B22-(pyridin-2YL)-1, 7-diaza-spiro [4.4] nonane-6-one compound as voltage-gated sodium channels modulatorCONVERGENCE PHARMACEUTICALS·Filed 2012·Granted Apr 5, 2016·0 cites·7 claims
- 1159US2016184306A1Novel Pyrimidinyl-DiazoSpiro CompoundsCONVERGENCE PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 1258US10231950B2Erythromelalgia treatmentCONVERGENCE PHARMACEUTICALS·Filed 2015·Granted Mar 19, 2019·1 cites·9 claims
- 1352US2020147041A1Paroxysmal extreme pain disorder treatmentCONVERGENCE PHARMACEUTICALS·Filed 2019·Application pending·0 cites
- 1449US2016185758A12-(Pyridin-2-yl)-1, 7-Diaza-Spiro [4.4] Nonane-6-One Compound as Voltage-Gated Sodium Channel ModulatorCONVERGENCE PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 1540US9750719B2Tetrazole compounds as calcium channel blockersCONVERGENCE PHARMACEUTICALS·Filed 2015·Granted Sep 5, 2017·0 cites·18 claims
- 1639US2019388391A1Novel erythromelalgia treatmentCONVERGENCE PHARMACEUTICALS·Filed 2019·Application pending·0 cites
- 1738US2017096708A1Diagnostic methodCONVERGENCE PHARMACEUTICALS·Filed 2015·Application pending·0 cites
- 1837US10493059B2Paroxysmal extreme pain disorder treatmentCONVERGENCE PHARMACEUTICALS·Filed 2015·Granted Dec 3, 2019·0 cites·5 claims
- 1923US2017290802A1Novel Small Fibre Neuropathy TreatmentCONVERGENCE PHARMACEUTICALS·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →